Company overview
Pharmagene Discovery Services is a contract research organisation specializing in human tissue-based drug discovery and preclinical research. Operating since 1996 from Cambridge, UK, the company provides customized assay development, spatial biology analysis, target validation, biomarker discovery, and biotherapeutic safety testing using consented human biospecimens. Their services support pharmaceutical, biotechnology, and patient foundation clients throughout the drug discovery and development pipeline.
Human Tissue Research CRO is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services, Diagnostics & Testing partner serving United States & Americas. Core focus areas include human tissue research, drug discovery cro, biomarker discovery, preclinical testing, in vitro assays.
Industry categories: CRO & Clinical Services, Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Human Tissue Research CRO include Assay, Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.pharmagene.com
- Categories
- CRO & Clinical Services, Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- human tissue research, drug discovery cro, biomarker discovery, preclinical testing, in vitro assays
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What are Pharmagene's core service offerings?
- Pharmagene provides human tissue-based assays, spatial biology interrogation, functional cellular biology studies, bioassays, target expression analysis, disease characterization, therapeutic target validation, biomarker discovery, and biotherapeutic safety testing in human tissues and primary human cells.
- What regulatory standards and certifications does Pharmagene maintain?
- Pharmagene operates to GLP (Good Laboratory Practice) standards and is licensed by the UK Human Tissue Authority, ensuring compliance with regulatory requirements for human tissue research.
- Does Pharmagene maintain tissue samples and biospecimens?
- Yes, Pharmagene has created and curates an in-house human tissue biorepository to support client research. The company also offers sample processing and biostorage services to support ongoing studies.
- How does Pharmagene reduce reliance on animal testing?
- Pharmagene specializes in designing and implementing innovative in vitro models and tissue-based platforms using human biospecimens, enabling researchers to generate human-relevant data while reducing dependence on animal testing.
- What types of organizations does Pharmagene partner with?
- Pharmagene partners with global life science organizations including biopharmaceutical companies, biotechnology firms, and patient foundations, providing customized discovery and preclinical research services.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
